Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 28, 2002
- Accepted after revision January 7, 2003
- Accepted after revision January 7, 2003
- Published online June 1, 2003.
Copyright & Usage
Copyright © American Society of Neuroradiology
Author Information
- aDevelopmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD
- bFunctional MRI Facility, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD
- cDiagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, MD
- Address reprint requests to Raphael Schiffmann, MD, National Institutes of Health, Bldg 10, Rm 3D03, 9000 Rockville Pike, Bethesda, MD 20892-1260
Altmetrics
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study
- Redefining the Pulvinar Sign in Fabry Disease
- Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation
- Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration
- Brain Magnetic Resonance Imaging Findings Fail to Suspect Fabry Disease in Young Patients With an Acute Cerebrovascular Event
- Pulvinar: Associative role in cortical function and clinical correlations
- Cerebrovascular Involvement in Fabry Disease: Current Status of Knowledge
- Is CT Still Useful in the Study Protocol of Retinoblastoma?
- Invited Article: An MRI-based approach to the diagnosis of white matter disorders
- Diagnostic utility of different MRI and MR angiography measures in Fabry disease
- Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study
- Voxel based analyses of diffusion tensor imaging in Fabry disease
- Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach
- Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalities